Model
Edge
Alnylam Pharmaceuticals, Inc.
0001446125
Filing type
4
Filing date
Mar 3, 2026
Updated
Mar 4, 2026 ยท 5:29 PM
Copy reference
Filing
4
Statement of Changes in Beneficial Ownership